University of California San Diego study: Targeted cognitive training benefits patients with severe schizophrenia

8 Dec

Bethany Yeiser wrote in the Psychology Today article, Schizophrenia and Homelessness: Paranoia drove me to sleep outside:

Over the past few years, I have been contacted by several families who have a loved one struggling with schizophrenia. Many of these people with schizophrenia are homeless.
For me, becoming homeless was a direct result of schizophrenia. Because of the illness, I could not work the easiest job or focus enough to take even one class. The illness brought on a paranoia which led me to cut off all my family members and my closest friends.
While homeless, I badly wanted a place to sleep, as I was tired of sleeping outside in a churchyard. Remarkably, I was given plenty of opportunities to leave my homeless life, and I rejected every one of them…. https://www.psychologytoday.com/us/blog/recovery-road/201807/schizophrenia-and-homelessness

SARDAA has information about schizophrenia.

In Quick Facts About Schizophrenia, SARDAA reported:

Quick Facts About Schizophrenia
• Schizophrenia can be found in approximately 1.1% of the world’s population, regardless of racial, ethnic or economic background
• Approximately 3.5 million people in the United States are diagnosed with schizophrenia and it is one of the leading causes of disability.
• Three-quarters of persons with schizophrenia develop the illness between 16 and 25 years of age.
• The disorder is at least partially genetic.
• To be diagnosed as having schizophrenia, one must have associated symptoms for at least six months.
• Studies have indicated that 25% of those having schizophrenia recover completely, 50% are improved over a 10-year period, and 25% do not improve over time.
• Treatment and other economic costs due to schizophrenia are enormous, estimated between $32.5 and $65 billion annually.
• Between one-third and one-half of all homeless adults have schizophrenia.
• 50% of people diagnosed with schizophrenia have received no treatment.
To learn more, we invite you to view a presentation by Linda Whitten Stalters, APRN, BC, FAPA, SARDAA Board of Directors. https://www.slideshare.net/SARDAA https://sardaa.org/resources/about-schizophrenia/

The University of California San Diego reported that cognitive training might aid those suffering from schizophrenia.

Science daily reported in Targeted cognitive training benefits patients with severe schizophrenia:

Schizophrenia is among the most difficult mental illnesses to treat, in part because it is characterized by a wide range of dysfunction, from hallucinations and mood disorders to cognitive impairment, especially verbal and working memory, which can be explained in part by abnormalities in early auditory information processing.
In recent years, targeted cognitive training (TCT) has emerged as a promising therapeutic intervention. TCT uses computerized training, such as sophisticated brain games, to target specific neural pathways, such as memory, learning and auditory-based senses, to beneficially alter the way they process information.
But while TCT has proven effective for mild to moderate forms of schizophrenia under carefully controlled conditions, it remains unclear whether the approach might benefit patients with chronic, refractory schizophrenia treated in non-academic settings, such as those cared for in locked residential rehabilitation centers.
In a study published in the December print issue of Schizophrenia Research, senior author Gregory A. Light, PhD, professor of psychiatry at UC San Diego School of Medicine and director of the Mental Illness, Research, Education and Clinical Center at Veterans Affaris San Diego Healthcare System, and colleagues investigated whether TCT improved auditory and verbal outcomes among the most difficult of schizophrenia patients.
“Chronic, treatment-refractory patients mandated to locked residential care facilities make up just a small subgroup of persons with schizophrenia, but they consume a disproportionately large share of mental health care resources,” said Light. “Finding an effective therapy for them is critical.”
Light’s team studied 46 patients with schizophrenia psychosis recruited from a community-based residential treatment program, each following acute hospitalization. All were deemed “gravely disabled,” unable to care for themselves, and under the guardianship of a private party or government agency. Participants were randomized to either standard treatment-as-usual (TAU) or TAU plus TCT, in which they used laptop computers to perform various learning and memory game exercises, often involving auditory cues.
The researchers found that among participants who completed the roughly three months of TAU-TCT treatment, verbal learning and auditory perception scores improved; and severity of auditory hallucinations lessened. Of note: The benefits were not negatively impacted by age, clinical symptoms, medication or illness duration. “Our results suggest that chronically ill, highly disabled patients can benefit from TCT,” said Light. “That contradicts current assumptions.”
Light cited some caveats. “We’re somewhere between the Wild West and golden age of cognitive training for schizophrenia patients. There is much still to be learned and done,” he said. Patients in this study represented some of the most difficult patients to treat, with therapy regimens that are highly complex. “We need to do a lot more research….” https://www.sciencedaily.com/releases/2018/12/181207112759.htm

Citation:

Targeted cognitive training benefits patients with severe schizophrenia
Study participants improved auditory and verbal outcomes
Date: December 7, 2018
Source: University of California – San Diego
Summary:
Researchers find that patients with severe, refractory schizophrenia benefit from targeted cognitive therapy, improving auditory and verbal outcomes and the way they process information.
Journal Reference:
Michael L. Thomas, Andrew W. Bismark, Yash B. Joshi, Melissa Tarasenko, Emily B.H. Treichler, William C. Hochberger, Wen Zhang, John Nungaray, Joyce Sprock, Lauren Cardoso, Kristine Tiernan, Mouna Attarha, David L. Braff, Sophia Vinogradov, Neal Swerdlow, Gregory A. Light. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophrenia Research, 2018; 202: 378 DOI: 10.1016/j.schres.2018.07.025

Here is the press release from University of California San Diego:

PUBLIC RELEASE: 6-DEC-2018
Targeted cognitive training benefits patients with severe schizophrenia
Study participants improved auditory and verbal outcomes
UNIVERSITY OF CALIFORNIA – SAN DIEGO
Schizophrenia is among the most difficult mental illnesses to treat, in part because it is characterized by a wide range of dysfunction, from hallucinations and mood disorders to cognitive impairment, especially verbal and working memory, which can be explained in part by abnormalities in early auditory information processing.
In recent years, targeted cognitive training (TCT) has emerged as a promising therapeutic intervention. TCT uses computerized training, such as sophisticated brain games, to target specific neural pathways, such as memory, learning and auditory-based senses, to beneficially alter the way they process information.
But while TCT has proven effective for mild to moderate forms of schizophrenia under carefully controlled conditions, it remains unclear whether the approach might benefit patients with chronic, refractory schizophrenia treated in non-academic settings, such as those cared for in locked residential rehabilitation centers.
In a study published in the December print issue of Schizophrenia Research, senior author Gregory A. Light, PhD, professor of psychiatry at UC San Diego School of Medicine and director of the Mental Illness, Research, Education and Clinical Center at Veterans Affaris San Diego Healthcare System, and colleagues investigated whether TCT improved auditory and verbal outcomes among the most difficult of schizophrenia patients.
“Chronic, treatment-refractory patients mandated to locked residential care facilities make up just a small subgroup of persons with schizophrenia, but they consume a disproportionately large share of mental health care resources,” said Light. “Finding an effective therapy for them is critical.”
Light’s team studied 46 patients with schizophrenia psychosis recruited from a community-based residential treatment program, each following acute hospitalization. All were deemed “gravely disabled,” unable to care for themselves, and under the guardianship of a private party or government agency. Participants were randomized to either standard treatment-as-usual (TAU) or TAU plus TCT, in which they used laptop computers to perform various learning and memory game exercises, often involving auditory cues.
The researchers found that among participants who completed the roughly three months of TAU-TCT treatment, verbal learning and auditory perception scores improved; and severity of auditory hallucinations lessened. Of note: The benefits were not negatively impacted by age, clinical symptoms, medication or illness duration. “Our results suggest that chronically ill, highly disabled patients can benefit from TCT,” said Light. “That contradicts current assumptions.”
Light cited some caveats. “We’re somewhere between the Wild West and golden age of cognitive training for schizophrenia patients. There is much still to be learned and done,” he said. Patients in this study represented some of the most difficult patients to treat, with therapy regimens that are highly complex. “We need to do a lot more research.”
Light and others are doing so. In a recent paper published in Neuropsychopharmacology, for example, he and colleagues described the underlying mechanism involved in TCT to improve auditory function. And in past work, schizophrenia-and-auditory-cues.aspx Light and others have shown that deficiencies in the neural processing of simple auditory tones can evolve into a cascade of dysfunctional information processing in the brains of patients with schizophrenia.
###
This study was made available online in July 2018 ahead of peer-review and publication this month.
Co-authors include: Michael L. Thomas, Andrew W. Bismark, Yash B. Joshi, Melissa Tarasenko, Emily B.H. Treichler, William C. Hochberger, Joyce Sprock, David L. Braff and Neal Swerdlow, UC San Diego and Veterans Affairs San Diego Healthcare System; Wes Zhang, SDSU-UCSD Joint Doctoral Program in Clinical Psychology; John Nungaray, UC San Diego; Lauren Cardoso, UC San Diego and Alpine Special Treatment Center; Mouna Attarha, Alpine Special Treatment Center; and Sophia Vinogradov, University of Minnesota.
Disclosures: Dr. Greg Light has been a consultant to Astellas, Boehringer-Ingelheim, Dart Neuroscience, Heptares, Lundbeck, Merck, NeuroSig, Neuroverse and Takeda. Dr. Mouna Attarha is a research scientist and stock holder at Posit Science Corporations, which developed the computerized brain training program used in the study.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Science Daily reported in Roots of schizophrenia: Excess of methionine during pregnancy?

An abundance of an amino acid called methionine, which is common in meat, cheese and beans, may provide new clues to the fetal brain development that can manifest in schizophrenia, University of California, Irvine pharmacology researchers report in the journal Molecular Psychiatry.
The findings point to the role methionine overload can play during pregnancy and suggest that targeting the effects of this amino acid may lead to new antipsychotic drugs….
https://www.sciencedaily.com/releases/2017/08/170816100305.htm

Citation:

Roots of schizophrenia: Excess of methionine during pregnancy?
Date: August 16, 2017
Source: University of California – Irvine
Summary:
An abundance of an amino acid called methionine, which is common in meat, cheese and beans, may provide new clues to the fetal brain development that can manifest in schizophrenia, pharmacology researchers report.
Journal Reference:
1. A Alachkar, L Wang, R Yoshimura, A R Hamzeh, Z Wang, N Sanathara, S M Lee, X Xu, G W Abbott, O Civelli. Prenatal one-carbon metabolism dysregulation programs
schizophrenia-like deficits. Molecular Psychiatry, 2017; DOI: 10.1038/mp.2017.164

Here is the press release from UC Irvine:

Public Release: 15-Aug-2017
UCI study uncovers possible roots of schizophrenia
Excess of methionine during pregnancy alters prenatal brain development related to the psychiatric disease
University of California – Irvine
Irvine, Calif., Aug. 15, 2017 – An abundance of an amino acid called methionine, which is common in meat, cheese and beans, may provide new clues to the fetal brain development that can manifest in schizophrenia, University of California, Irvine pharmacology researchers report in the journal Molecular Psychiatry.
The findings point to the role methionine overload can play during pregnancy and suggest that targeting the effects of this amino acid may lead to new antipsychotic drugs.
The UCI study also provides detailed information on the neural developmental mechanisms of the methionine effect, which results in changes in the expression of several genes important to healthy brain growth and, in particular, to one linked to schizophrenia in humans.
Amal Alachkar and colleagues based their approach on studies from the 1960s and 1970s in which schizophrenic patients injected with methionine experienced worsened symptoms. Knowing that schizophrenia is a developmental disorder, the UCI team hypothesized that administering three times the normal daily input of methionine to pregnant mice may produce pups that have also schizophrenia-like deficits, which is what occurred.
The pups of the injected mothers displayed deficits in nine different tests encompassing the three schizophrenia-like symptoms behaviors – “positive” symptoms of overactivity and stereotypy, “negative” symptoms of human interaction deficits, and “cognitive impairments” memory loss.
The research team treated the mice with anti-schizophrenic drugs well used in therapy. A drug that in schizophrenics treats mostly the positive symptoms (haloperidol) did the same in the mice, and a drug that treat preferentially the negative symptoms and the cognitive impairments (clozapine) did the same.
Alachkar, an associate adjunct professor of pharmacology, said that the study is the first to present a mouse model based on methionine-influenced neural development that leads to schizophrenic-like behaviors.
“This mouse model provides much broader detail of biological processes of schizophrenia and thus reflect much better the disorder than in the animal models presently widely used in drug discovery,” said Olivier Civelli, chair and professor of pharmacology and an author on the paper.
“Our study also agrees with the saying, ‘we are what our mothers ate’,” Alachkar added. “Methionine is one of the building blocks of proteins. It is not synthesized by our bodies, and it needs to be ingested. Our study points at the very important role of excess dietary methionine during pregnancy in fetal development, which might have a long-lasting influence on the offspring. This is a very exciting area of research that we hope can be explored in greater depth.”
###
The study received support from the National Institutes of Health (DA024746), the UCI’s Center for Autism Research & Translation, the Eric L and Lila D Nelson Chair of Neuropharmacology, and the Institute of International Education.
Link to study: http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2017164a.html?foxtrotcallback=true
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
Media Contact
Tom Vasich
tmvasich@uci.edu
949-824-6455
@UCIrvine
http://www.uci.edu
University of California – Irvine
Journal
Molecular Psychiatry
Funder
National Institutes of Health
Original Source
http://www.som.uci.edu/news_releases/uc-irvine-study-finds-possible-roots-of-schizophrenia.asp

Related Journal Article
http://dx.doi.org/10.1038/mp.2017

Learn more about prenatal and preconception care.
http://www.nichd.nih.gov/health/topics/preconceptioncare/Pages/default.aspx

http://www.nichd.nih.gov/health/topics/pregnancy/conditioninfo/Pages/prenatal-care.aspx

See, Prenatal care fact sheet http://www.womenshealth.gov/publications/our-publications/fact-sheet/prenatal-care.html

Our goal as a society should be a healthy child in a healthy family who attends a healthy school in a healthy neighborhood. ©

Where information leads to Hope. © Dr. Wilda.com

Dr. Wilda says this about that ©

Blogs by Dr. Wilda:

COMMENTS FROM AN OLD FART©
http://drwildaoldfart.wordpress.com/

Dr. Wilda Reviews ©
http://drwildareviews.wordpress.com/

Dr. Wilda ©
https://drwilda.com/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: